Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M004453200 on July 7, 2000

J. Biol. Chem., Vol. 275, Issue 42, 32931-32939, October 20, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/42/32931    most recent
M004453200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ko, Y. H.
Right arrow Articles by Pedersen, P. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ko, Y. H.
Right arrow Articles by Pedersen, P. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Mitochondrial F0F1 ATP Synthase

SUBUNIT REGIONS ON THE F1 MOTOR SHIELDED BY F0, FUNCTIONAL SIGNIFICANCE, AND EVIDENCE FOR AN INVOLVEMENT OF THE UNIQUE F0 SUBUNIT F6*

Young Hee Ko, Joanne Hullihen, Sangjin Hong, and Peter L. PedersenDagger

From the Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205-2185

Received for publication, May 23, 2000, and in revised form, June 28, 2000


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Studies reported here were undertaken to gain greater molecular insight into the complex structure of mitochondrial ATP synthase (F0F1) and its relationship to the enzyme's function and motor-related properties. Significantly, these studies, which employed N-terminal sequence, mass spectral, proteolytic, immunological, and functional analyses, led to the following novel findings. First, at the top of F1 within F0F1, all six N-terminal regions derived from alpha  + beta  subunits are shielded, indicating that one or more F0 subunits forms a "cap." Second, at the bottom of F1 within F0F1, the N-terminal region of the single delta  subunit and the C-terminal regions of all three alpha  subunits are shielded also by F0. Third, and in contrast, part of the gamma  subunit located at the bottom of F1 is already shielded in F1, indicating that there is a preferential propensity for interaction with other F1 subunits, most likely delta  and epsilon . Fourth, and consistent with the first two conclusions above that specific regions at the top and bottom of F1 are shielded by F0, further proteolytic shaving of alpha  and beta  subunits at these locations eliminates the capacity of F1 to couple a proton gradient to ATP synthesis. Finally, evidence was obtained that the F0 subunit called "F6," unique to animal ATP synthases, is involved in shielding F1. The significance of the studies reported here, in relation to current views about ATP synthase structure and function in animal mitochondria, is discussed.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

ATP synthases represent one of natures' most unique enzyme classes (reviewed in Refs. 1-3). Structurally, these enzymes are observed by electron microscopy (4-12) to consists of four distinct features, a headpiece, a basepiece, a central stalk or "stem region" connecting the headpiece and basepiece, and a "second stalk" extending from the basepiece to the top of the headpiece (4-10). Animal ATP synthases contain, in addition, what appears to be a fifth structural feature, a ring-like disc or "collar" surrounding the central stalk (11). Biochemically, however, ATP synthases separate most readily into only two units. One is a water-soluble component, F1, containing five subunit types in the ratio alpha 3beta 3gamma delta epsilon , whereas the other is a detergent-soluble component, F0, containing three subunit types (a, b, c) in bacteria and at least 10 more in animal systems (1-3). A regulatory protein, IF1, is found also in isolated mitochondrial ATP synthases. A variety of studies involving biochemica1 (13-25), electron microscopic (4-12), and x-ray crystallographic (26-30) approaches, have shown that the headpiece and central stalk are derived primarily from F1 subunits and the basepiece and second stalk are derived primarily from F0 subunits. In contrast, the subunit source of the ring-like disc or "collar" surrounding the central stalk in animal ATP synthases (11) remains unknown.

Nature's rationale for providing ATP synthases with this unique molecular architecture has become apparent only in recent studies where evidence that these fascinating enzymes contain two motors has been mounting (31-33). One of the proposed motors is F1, which is driven by ATP binding and/or hydrolysis (31), whereas the other is contained within F0 and driven by a proton gradient (33). During ATP synthesis, the proposed motor within F0, composed of 10-12 subunit c molecules (30, 34) and a single subunit a, is believed to drive the F1 motor in reverse (35) via a central rotor, the F1-gamma subunit. This subunit extends from a ring of subunit c molecules in the F0 basepiece (19), through the central stalk region, and finally through the center of F1 where it interacts differently with each of the three alpha beta pairs (26-29). During one 360° rotation of the gamma  subunit, the binding of ADP and inorganic phosphate, the synthesis of ATP, and the release of this ATP are believed to occur on each alpha beta pair as proposed by the "binding change mechanism" (2, 36). During this process, the epsilon  subunit in bacteria, or its delta  subunit equivalent in animals, is also believed to rotate (32), presumably at the bottom of F1 within the central stalk region.

Although much has been learned about the structure and function of ATP synthases as summarized above, a three-dimensional structure has not been obtained for the complete enzyme (F0F1) from any source. In fact, of the 16 different subunit types within the mitochondrial ATP synthase of animal cells, only two and a half of these (alpha , beta , and about half of gamma ) have been solved at atomic resolution (26, 28). Consequently, there are still many important questions that remain unanswered about structure/function relationships in ATP synthases, and how, within these remarkably complex machines, energy coupling between the proposed proton gradient-driven motor within F0 is coupled to the reversal of the ATP-driven F1 motor. Specifically, one important question relates to the identity of exterior subunit regions at the top and bottom of F1 that are shielded by F0 in the complete ATP synthase, because these regions may include F0/F1 contact sites essential for energy coupling during ATP synthesis. Although information about these regions, particularly at or near the top of F1, is gradually being generated for the Escherichia coli and chloroplast enzymes (12, 23), little information is available for animal ATP synthases.

In studies reported below, we used a variety of approaches to identify exterior subunit regions at the top and bottom of rat liver F1 that are shielded by F0. We then assessed the requirement of these regions for coupling a proton gradient to ATP synthesis. In addition, we obtained evidence for the involvement of an F0 subunit unique to animal ATP synthases.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials

Rats (Harlan Sprague-DawleyCD, white males) were obtained from Charles River Breeding Laboratories. ATP, MgCl2, 2EDTA, DTT,1 tricine, Sephadex G-25 (coarse), soybean trypsin inhibitor, oligomycin, and DCCD were from Sigma. SDS, acrylamide, and bisacrylamide were from Bio-Rad, PVDF membranes from Millipore, and Western blot reagents from Amersham Pharmacia Biotech. Modified trypsin (sequencing grade), pyroglutamate aminopeptidase, hexokinase, and glucose-6-phosphate dehydrogenase were from Roche Molecular Biochemicals. The detergent CHAPS was obtained from Anatrace, whereas sucrose, urea, and potassium phosphate were from J.T. Baker. Coomassie Blue dye binding reagent for protein determination was from Pierce, AEBSF was from Calbiochem, and 3,5-dimethoxy-4-hydroxy-cinnamic acid and alpha -cyano-4-hydroxy-cinnamic acid were from Aldrich. Centriprep filtration units for protein concentration were from Amicon. Venturicidin was from BDH Chemicals. The antibodies to F0 components were generous gifts from Drs. Y. Hatefi and Akemi Matsuno Yagi. All other products were of the highest purity or grade commercially available.

Methods

Purification of Mitochondrial ATP Synthase (F0F1)-- This complex was purified from rat liver mitochondria by a modification of a previously described method developed in this laboratory (6). A washed submitochondrial particle fraction, referred to previously as 3X membranes (6), was stored at ~15 mg/ml and -20 °C in TA buffer (50 mM Tricine, 1 mM ATP, 25 mM EDTA, 0.5 mM DTT, and 5% ethylene glycol, pH 7.9), thawed, and solubilized at 4 mg/ml in 0.6% CHAPS for l h on ice with occasional stirring. After centrifugation for 1 h at 48,000 rpm at 4 °C in a 70.1-Ti rotor in a Beckman Optima LE 80K ultracentrifuge to remove unsolubilized material, the supernatant was concentrated using Amicon's Centriprep filtration unit (molecular mass cutoff = 50 kDa). The concentrate was diluted with TA buffer to give a CHAPS concentration of 0.1% and frozen in dry ice and ethanol, and then stored at -20 °C for 3 h. The sample (~20 ml) was then thawed, and 5-ml aliquots (2.0-2.5 mg/ml) were placed on 20 ml of 25% sucrose in TA buffer without CHAPS and centrifuged 12 h and 45 min at 4 °C in the same centrifuge described above but using the SW-28 rotor. The pellet, F0F1 (7-10 mg/ml), judged to be >90% pure, was stored at -80 °C in TA buffer. The specific activity was 14-15 µmol of ATP hydrolyzed × min-1 × mg-1 protein based on the ATPase and protein assays described below.

Purification of the F1 Moiety of Mitochondrial ATP Synthase-- F1 with a specific activity of about 25 µmol × min-1 × mg-1 in TrisCl buffer was purified from isolated rat liver mitochondria exactly as described by Catterall and Pedersen (37) with one modification. The terminal Sephadex G-200 step was replaced by chromatography on a 2.1- × 13-cm Sephadex G-25 column packed on top of a 1.5-cm layer of sea sand and a 1-cm layer of glass wool. It was then stored or prepared for use as described by Ko et al. (38).

Preparation of Inner Mitochondrial Membrane Vesicles and F1-depleted Vesicles, and Reconstitution of F1 with the F1-depleted Vesicles-- All steps were carried out exactly as described previously by Pedersen and Hullihen (39).

Treatment of F0F1 with Pyroglutamate Aminopeptidase-- To remove the N-terminally blocked group on the alpha  subunit, F0F1 (1 mg/ml) was placed in a 200 µl of digestion buffer containing 100 mM sodium Pi, pH 8.0, 10 mM EDTA, 5 mM DTT, 5% glycerol, 0.6% CHAPS, and pyroglutamate aminopeptidase (0.019 mg/ml). The enzyme was then incubated in this mixture first for 12 h at 4 °C and then for 2 h at 25 °C, after which the entire reaction mixture was added to SDS sample buffer and analyzed by SDS-PAGE. The alpha  subunit band was then subjected to N-terminal sequence analysis exactly as described below.

Treatment of F1 and F0F1 with Trypsin-- F1 and F0F1 (each 160 µg) were subjected to digestion for various incubation times at 25 °C in a final volume of 0.1 ml containing 250 mM potassium Pi, pH 7.5, 5 mM EDTA, and 10 µg of trypsin. Trypsin inhibitor (50 µg), or AEBSF at a final concentration of 5 mM, was then added at various incubation times to stop the reaction. Following the addition of ammonium sulfate to the mixture to give 65% saturation, the resultant suspension was centrifuged at 13, 000 rpm in a Sorvall SS 34 rotor for 1 h at 25 °C.

Assay for ATPase Activity-- ATPase activity was assayed exactly as described previously (37) by a spectrophotometric procedure in which ADP formed was coupled to the pyruvate kinase and lactic dehydrogenase reactions.

Assay for ATP Synthesis-- ATP synthesis was monitored spectrophotometrically at 340 nm and 25 °C by coupling the production of ATP to the reduction of NADP+ via the hexokinase and glucose-6-phosphate dehydrogenase reactions. The assay mixture contained, in a final volume of 1 ml, 10 mM potassium Pi, 10 mM succinate, 50 mM Tris acetate, 1 mM glucose, 1 mM NADP+, 2.0 mM MgCl2, 2 mg/ml bovine albumin, 200 mM sucrose, 20 IU hexokinase, 0.25 IU glucose-6-phosphate dehydrogenase, and 100-200 µg of inner mitochondrial membrane vesicles. The reaction was started by the addition of 1 mM ADP.

SDS-PAGE-- This was carried out as indicated either by the method of Laemmli (40) or the more sensitive method of Schägger and von Jagow (41) for separating proteins in the molecular mass range of from 1 to 100 kDa.

Western Analysis-- After conducting SDS-PAGE, the proteins on the gel were transferred electrophoretically at 4 °C in 10 mM CAPS, 10% methanol transfer buffer, pH 11, onto a PVDF membrane (1 h at 100 V and 0.2 amp). The membrane was then blocked for l h with 2% bovine albumin plus 5% non-fat dry milk in phosphate-buffered saline T buffer (80 mM Na2HPO4, 20 mM NaH2PO4, 100 mM NaCl, 0.1% Tween 20, pH 7.5), incubated for 1 h at 23 °C with polyclonal antibodies as indicated in the figure legends, and then further incubated for 1 h at 23 °C with secondary antibody (horseradish peroxidase-conjugated anti-rabbit IgG). The immunoreactive bands were detected by an enhanced chemiluminescence (ECL) system.

Mass Spectral Analysis-- Mass spectra were acquired on samples of 10-20 pmol in a PerSeptive Biosystems Voyager MALDI-TOF-DE mass spectrometer using a nitrogen laser (wavelength 337 nm). The matrix was either 3,5-dimethoxy-4-hydroxy-cinnamic acid or alpha -cyano-4-hydroxy-cinnamic acid. Positive ion mass spectra were analyzed using PerSeptive GRAMS software version 3.01c.

N-terminal Sequence Analysis-- F1 or F0 subunits were transferred from SDS-PAGE gels onto PVDF membranes by electroblotting. Transfer conditions were for 1 h in 10 mM CAPS buffer, 10% methanol, pH 11, at 4 °C. The peptides were then excised and subjected to N-terminal sequencing (42) using an Applied Biosystems 475A protein sequencing system (43).

Determination of Protein-- Three different methods were used to determine protein, Lowry et al. (44), biuret (45), and Coomassie dye (Pierce). In all cases bovine albumin was used as the standard.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Objectives and Systems Employed-- The first objective of this study was to identify exterior regions on F1 that are shielded by F0 within a fully active, complete ATP synthase (F0F1) preparation from an animal mitochondrial source. The regions on F1 of most interest (Fig. 1A) were its top where the N-terminal regions of alpha  and beta  subunits reside (26-28) and its bottom where the C-terminal regions of these same subunits (26-28) reside together with part of the gamma  subunit (26, 28), the delta  subunit (25, 30), and likely also the epsilon  subunit. The second objective was to assess the importance of these regions for coupling an electrochemical proton gradient to ATP synthesis. This information is generally lacking for animal ATP synthases, which are much more complex in their F0 subunit composition than related enzymes from E. coli and chloroplasts. The third objective was to identify at least one F0 subunit unique to the animal enzyme involved in shielding F1, because such a subunit would represent a candidate for part of the stator or second stalk believed to stabilize the F1 motor. To complete these objectives, it was essential to have at hand, in addition to our extensively studied rat liver F1 preparation (25, 28, 37-39), an intact, highly purified preparation of the complete ATP synthase from the same source. This was accomplished by introducing several modifications (see "Methods") into the CHAPS-based procedure previously developed in this laboratory (6). The resultant preparation exhibits a specific activity of 14-15 µmol of ATP hydrolyzed × min-1 × mg-1 protein, contains all 16 subunits (Fig. 1B) previously reported for the bovine heart ATP synthase (20), and is markedly inhibited by oligomycin, DCCD, and venturicidin (Fig. 1C), agents known to bind to F0 (46, 47).


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 1.   A, structure of rat liver F1 at 2.8 Å (28) depicting those regions examined in this study for possible shielding by subunits of F0. The ribbon representation of the F1 structure was constructed using the atomic coordinates of the rat liver enzyme (1mab (28)) using the program Quanta. The alpha -helical, beta -sheet, and loop structures are colored in green, yellow, and purple, respectively. Nucleotides are shown in red. Regions examined in this study are located at the top and bottom of F1. These include the N-terminal regions of the alpha  and beta  subunits (top) and the C-terminal regions of these same subunits (bottom), together with the central stalk ("stem") region (bottom). The central stalk region includes two sections, one that projects about 20 Å out of the F1 headpiece as revealed by x-ray crystallography (28) and shown in the figure, and another section (not shown) that is not yet resolvable by x-ray crystallography and is predicted to extend about another 30 Å (30). Regions of the gamma  subunit that were resolved by crystallography include residues 4-48, 209-273, and 77-90 (28). The delta  subunit (not shown) is believed to be located also within the region of the central stalk, both on the basis of biochemical studies (25) and on the basis of the recent structure at 3.9-Å resolution of a yeast F1-(subunit c)10 complex (30). B, SDS-PAGE gels of F1 and F0F1 preparations used in this study. F1 and F0F1 were purified and subjected to SDS-PAGE as described under "Methods." The presence of all known F0F1 subunits (16) was confirmed by N-terminal sequence analyses ("Methods") and/or by Western analyses ("Methods") using specific antibodies. C, results of ATPase assays demonstrating that the F0F1 preparation used in this study is inhibited by agents known to act at the level of F0. ATPase assays were carried out in a 1-ml system as indicated under "Methods." In all cases, 14 µg of F0F1 was used to initiate the assay, and where shown the following inhibitors were added: oligomycin (2.5 µg), DCCD (5 µg), or venturicidin (5 µg).

Evidence That the N-terminal Regions of the alpha  and beta  Subunits Located at the Top of F1 Are Shielded by One or More F0 Subunits in the Complete ATP Synthase-- Here, studies focused on the N-terminal regions of the three alpha  and three beta  subunits as they are known from the atomic resolution structures of bovine heart and rat liver F1 (Fig. 1A) to project from the top of the enzyme (26, 28). To determine whether one or more of the six N-terminal regions derived from these subunits are shielded by F0, we compared the extent to which F1, both alone and as part of the complete ATP synthase complex (F0F1), is shaved by endogenous proteases during purification. This necessitated carrying out N-terminal sequence analysis on both the alpha  and beta  subunits of preparations of rat liver F1 and F0F1 purified as described under "Methods." Therefore, following purification, these subunits were transferred from SDS-PAGE gels onto PVDF membranes by electroblotting, excised, and subjected to sequence analyses, also as described under "Methods." In these experiments, the N-terminal regions of alpha  subunits derived from the F0F1 preparation could be sequenced only following prior treatment with the enzyme pyroglutamate aminopeptidase (48), which removes from the blocked N termini pyrrolidone carboxylic acid (Fig. 2A, inset), a cyclic form of glutamine.


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 2.   A and B, N-terminal sequences obtained for the alpha  and beta  subunits within purified preparations of F0F1. The sequence of the alpha  subunit was obtained following removal of the cyclic glutamine residue (A, inset) blocking the N terminus. Removal of the cyclic glutamine residue, preparation of samples for N-terminal sequence analyses, and the sequencing method used are described under "Methods." C and D, N-terminal sequences obtained for the alpha  and beta  subunits within purified preparations of F1. See "Methods" for procedural details. E, summary of A-D. The summary diagram emphasizes that, when F1 is isolated in the absence of F0, endogenous proteases cleave 2 amino acids, Q and K from the N-terminal region of alpha  subunits and a 6 amino acid peptide, AAQSSA, from the N-terminal region of beta  subunits.

The results of these experiments revealed that the N-terminal regions of all alpha  and beta  subunits remain intact in F0F1 during its purification from mitochondria, because the amino acid sequences obtained (Fig. 2, A and B) correspond to those predicted for the mature sequences of these subunits. In contrast, the same subunits are shaved during the purification of F1 (Fig. 2, C and D). Thus, two amino acids, Q and K, are shaved from alpha  subunits, whereas the 6-amino acid peptide, AAQSSA, is shaved from beta  subunits (Fig. 2E). The degree of shaving remained the same in a number of F1 preparations examined. In all cases the N-terminal sequence data obtained was homogeneous, thus ruling out the possibility of differences among the N-terminal regions of each of the three alpha  subunits and each of the three beta  subunits. These results indicate that, when within the complete ATP synthase, all six N-terminal regions of alpha  + beta  subunits located at the top of F1 are shielded during purification from specific proteases endogenous to the mitochondria. Moreover, they strongly implicate one or more F0 subunits as comprising this shield, which appears to "cap" the top of F1 rather than being confined to a limited region. Consistent with these conclusions, in experiments not reported here, treatment of purified F0F1 with trypsin for 1.5 h was unable to cleave the N-terminal regions of either the F1 alpha  or beta  subunits despite the presence of potential cleavage sites (R and/or K) in both cases.

Evidence That, of the Three Remaining Subunits (gamma , delta , and epsilon ), Only the N-terminal Region of delta , Located at the Bottom of F1, Is Shielded by One or More F0 Subunits in the Complete ATP Synthase-- A comparison of amino acid sequencing data presented in Figs. 3A and 3B, and summarized in 3G, shows that the N-terminal region of the gamma  subunit has not been shaved by proteases during isolation of F1. Rather, its N-terminal sequence is identical to that found in purified F0F1, and to the known sequence for this subunit. This is an expected result, which serves as a control. Thus, it is known from the atomic resolution structures of bovine heart and rat liver F1 preparations (26, 28) that the N-terminal region of the gamma  subunit is tucked deep inside the central cavity of the F1 headpiece where it is well shielded. In contrast, sequencing data for the delta  subunit presented in Figs. 3C and 3D, and summarized in 3G, show that in F1 purified alone a 4-amino acid peptide, AQAA, is shaved from its N-terminal region. However, when the delta  subunit is purified as part of the complete F0F1 complex, the AQAA peptide is retained. Finally, a comparison of N-terminal sequencing data presented in Figs. 3E and 3F, and summarized also in Fig. 3G, show that the epsilon  subunit, just as the gamma  subunit, has not been shaved during isolation, indicating that it may be shielded also within F1. To date, little is known about the precise location and role of the epsilon  subunit in mitochondrial ATP synthases, although it has been reported to subfractionate with a beta delta epsilon complex (49) and to bind to the delta  subunit (50).


View larger version (56K):
[in this window]
[in a new window]
 
Fig. 3.   A and B, N-terminal sequences obtained for the gamma  subunit within purified preparations of F0F1 (A) and F1 (B). Preparation of samples for N-terminal sequence analyses and the sequencing method used are described under "Methods." C and D, N-terminal sequences obtained for the delta  subunit within purified preparations of F0F1 (C) and F1 (D). Preparation of samples for N-terminal sequence analyses and the sequencing method used are described under "Methods." E and F, N-terminal sequences obtained for the epsilon  subunit within purified preparations of F0F1 (E) and F1 (F). Preparations of samples for N-terminal sequence analyses and the sequencing method used are described under "Methods." G, summary of A-F. The summary diagram emphasizes that the N-terminal regions of the gamma  and epsilon  subunits are not altered by endogenous proteases during purification of either F0F1 or F1, whereas the 4-amino acid peptide AQAA is cleaved from the N-terminal region of the delta  subunit in F1 but not F0F1.

The studies described here, taken together with the above studies, indicate that, within the complete liver mitochondrial ATP synthase, regions of F0 located at both the top and bottom of F1 shield the N-terminal regions of three of its subunit types (alpha , beta , and delta ), whereas the remaining two subunit types (gamma  and epsilon ) are shielded or tightly folded within F1.

Limited Treatment of Isolated F1 with Trypsin Results in Further Shaving of Its alpha  and beta  Subunits While Leaving the Smaller Subunits gamma , delta , and epsilon  Unaltered-- Results presented in Fig. 4 (A and B) show that treatment of isolated F1 with trypsin for as long as 90 min has no effect on the staining intensities or mobilities of the gamma , delta , and epsilon  subunits of F1 in SDS-PAGE gels but does noticeably affect the mobility of the alpha  subunit. Two different gel systems were used in these experiments. One contained 7.5% acrylamide (Fig. 4A), which separates best the alpha , beta , and gamma  subunits but not the delta  and epsilon  subunits, which migrate with the dye front. The second contained 15% acrylamide (Fig. 4B), which separates the gamma , delta , and epsilon  subunits better than the alpha  and beta  subunits.


View larger version (57K):
[in this window]
[in a new window]
 
Fig. 4.   A and B, SDS-PAGE pattern of F1 following limited treatment with trypsin. F1 was previously treated with trypsin exactly as described under "Methods" for the times indicated at the top of the gel and then subjected to SDS-PAGE in gels containing 7.5% (A) or 15% (B) polyacrylamide. The 7.5% gels resolved best the alpha , beta , and gamma  subunits of F1 but not the smaller subunits delta  and epsilon , which migrated with the dye front. In contrast the 15% gels resolved the subunits gamma , delta , and epsilon  better than the alpha  and beta  subunits. C and D, N-terminal sequences obtained for the alpha  subunits (C) and the beta  subunits (D) following treatment of F1 with trypsin for l h. The summary diagram at the bottom of C shows that trypsin shaves 13 amino acids more off the N-terminal region of the alpha  subunit than the 2 amino acids (Q and K) shaved off by endogenous proteases during purification (Fig. 2E). The summary diagram at the bottom of D shows that trypsin shaves only 3 amino acids more off the N-terminal region of the beta  subunit than the 6 (AAQSSA) shaved off by endogenous proteases during purification (Fig. 2E).

When all five F1 subunits from the SDS-PAGE gels were subjected to N-terminal sequence analyses, it was found that a 13-amino acid peptide (TGTAEMSSILEER) had been cleaved from the N-terminal region of the alpha  subunit (Fig. 4C) and a 3-amino acid peptide (APK) from the N-terminal region of the beta  subunit (Fig. 4D). In data not presented here, the N-terminal regions of the gamma , delta , and epsilon  subunits were found to be unaltered. Because the decrease in mass of the alpha  subunit appeared by inspection of SDS-PAGE gels (Fig. 4, A and B) to be greater than the mass of the 13-amino acid peptide cleaved from its N terminus, this suggested that trypsin may have cleaved also at the C terminus. For this reason we subjected both isolated F1 and trypsin-treated F1 to MALDI-TOF-DE mass spectral analysis as described under "Methods." Consistent with SDS-PAGE and N-terminal sequence analyses, these studies confirmed that the mass of the gamma , delta , and epsilon  subunits were unaltered and showed that the mass of each beta  subunit had decreased by only 341 Da (Fig. 5A), as expected from the loss of the APK peptide. In contrast, however, the mass of each alpha  subunit decreased by 4425 Da, of which only 1406 Da could be accounted for by the 13-amino acid peptide cleaved from the N-terminal region (Fig. 4C). Significantly, the remaining decrease in mass, which must come from the C-terminal region, corresponds most closely to a 26-amino acid alpha -helix resulting from trypsin cleavage between amino acid Arg-484 and Ser-485 (Fig. 5B).


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 5.   A, summary of molecular masses obtained for F1 subunits before and after limited treatment with trypsin. F1 was subjected to limited treatment with trypsin for 1 h exactly as described under "Methods" and then analyzed in a MALDI-TOF-DE mass spectrometer, also as described under "Methods." The masses obtained from two different experiments varied less than 1%. B, predicted trypsin cleavage site within the C-terminal region of the alpha  subunit. Taking into consideration the large total mass loss of the alpha  subunit, and the known loss of mass from its N-terminal region, the mass loss arising from its C-terminal region was calculated and found to correspond precisely to loss of the 26-amino acid peptide shown (see text for discussion). C, lack of effect of trypsin on the mobility of the alpha  and beta  subunits within purified F0F1. F0F1 was treated for up to 1.5 h with trypsin as described under "Methods" and then subjected to SDS-PAGE, also as described under "Methods."

These results, while demonstrating that limited trypsin treatment of isolated F1 causes further shaving of the exterior N-terminal regions of both the alpha  and beta  subunits located at the top of the molecule, and the exterior C-terminal helix of the alpha  subunit located at its bottom, also show that all three of the smaller subunits (gamma , delta , and epsilon ) are resistant to limited trypsin treatment. Significantly, in other studies it was shown that trypsin treatment of the complete ATP synthase (F0F1), in contrast to treatment of F1, had no detectable effect on the electrophoretic mobility of alpha  subunits in SDS-PAGE (Fig. 5C), indicating that F0 shields the C-terminal regions of all three of these subunits near the bottom of the F1 headpiece.

Trypsin-treated F1, Although Active as an ATPase and Capable of Rebinding to F0 within F1-depleted Inner Mitochondrial Membranes, Is Incapable of Coupling a Proton Gradient to ATP Synthesis-- Results presented in Fig. 6A show that those conditions under which trypsin further shaves the N-terminal regions of both alpha  and beta  subunits at the top of rat liver F1, and the C-terminal region of the alpha  subunits at its bottom (Figs. 4 and 5), are without effect on the capacity of the enzyme to catalyze ATP hydrolysis. Moreover, similar to isolated F1, trypsin-treated F1 is able to restore to F1-depleted inner membrane vesicles (IMVs) the capacity to catalyze high rates of ATP hydrolysis inhibited by oligomycin (Fig. 6B, left) and DCCD (not shown). This shows that trypsin-treated F1 is capable of binding appropriately to the basepiece of F0 where the sites of action of oligomycin (subunits c and a) and DCCD (subunit c) are located (46, 47). However, unlike isolated F1, which is able to restore the capacity of F1-depleted, actively respiring IMVs to catalyze ATP synthesis inhibited by oligomycin, DCCD (not shown), and the protonophore 2,4-dinitrophenol, trypsin-treated F1 is not effective in this capacity (Fig. 6B, right). (IMVs of rat liver mitochondria, prior to treatment with urea to deplete F1 and provide F1-depleted IMV, exhibit specific activities for ATP hydrolysis in the range of 2000-3000 nmol of ATP hydrolyzed × min-1 × mg-1 protein and specific activities for ATP synthesis in the range of 100-250 nmol × min-1 × mg-1 protein.)


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 6.   A, effect of trypsin on the ATPase activity of rat liver F1 as a function of time. F1 was treated with trypsin exactly as described under "Methods" for the times indicated and then assayed for ATPase activity by the spectrophotometric method, also described under "Methods." B, assessment of the capacity of trypsin-treated F1 to bind to F1-depleted inner mitochondrial membrane vesicles and restore ATPase and ATP synthetic activities. Preparation of F1-depleted inner membrane vesicles by treating inner membrane vesicles with 3.2 M urea, and reconstitution of F1 (300 µg) or trypsin-treated F1 (300 µg) with the depleted vesicles (0.5 mg), was carried out exactly as described previously (39). ATPase and ATP synthetic activities were assayed as described under "Methods." Where indicated, oligomycin (2.5 µg/ml), DCCD (5 µg/ml), or 2,4-dinitrophenol (100 µM) was added. Standard deviations are based on three different experiments. (In experiments not presented here, DCCD (5 µg/ml) inhibited by >90% the rates of ATP hydrolysis and ATP synthesis in all cases.)

These results indicate that one or more of the exterior, trypsin-accessible regions on F1 defined above are critical for coupling a proton gradient to ATP synthesis in the inner mitochondrial membrane, although they are of little or no importance to the enzyme for catalyzing ATP hydrolysis or for binding to F0.

Evidence for an Involvement of the Unique F0 Subunit Called F6 in Shielding F1-- Having acquired information that regions on rat liver F1, at its top and bottom, are shielded by F0, and that one or both of these locations on F1 may be necessary for coupling a proton gradient to ATP synthesis, our attention turned to the involvement of F0. Here the major goal was to identify one or more F0 subunits unique to the animal system involved in shielding F1 within the complete F0F1 ATP synthase. The F0 subunits named "F6," "OSCP," and "d" were considered to be likely candidates, because these subunits are not integral membrane proteins (18, 51, 52). The strategy employed took advantage of our knowledge that the N-terminal regions of each alpha  subunit shielded by F0 at the top of F1 has its N terminus blocked by pyrrolidone carboxylic acid. Therefore, it was rationalized that, by monitoring the ability of a deblocking enzyme to gain entrance to the N terminus of the blocked alpha  subunit in F0Fl after the addition of a mild dissociating agent, while monitoring the release of any F0 subunits, we might be able to identify one or more F0 subunits involved in shielding F1.

Based on the above strategy and considerable preliminary work, it was found that the deblocking enzyme (pyroglutamate aminopeptidase) gains access to the N terminus of the alpha  subunit after treatment of F0F1 with 0.6% CHAPS for 14 h (12 h at 4 °C and then 2 h at 25 °C). Thus, the N-terminal region of the alpha  subunit following SDS-PAGE and electroblotting onto a PVDF membrane could now be sequenced (Fig. 7A), verifying that deblocking had occurred. Significantly, M urea, when included under the above conditions, actually stabilized F0F1 and prevented the deblocking enzyme from gaining access to the N terminus of the alpha  subunit (Fig. 7B). When both the supernatant and pellet following treatment of F0F1 with CHAPS, but without urea, was analyzed by immunoblotting with an antibody specific for F6, all of this subunit was recovered in the supernatant (Fig. 7C, Condition 1). In contrast, when 1 M urea was present, F6 was not detected in the supernatant (Fig. 7C, Condition 2) but remained with the pellet. Experiments conducted in an identical manner but using antibodies specific for OSCP, showed that this subunit is also released into the supernatant (Fig. 7D, Condition 1). However, in this case 1 M urea fails to prevent its release (Fig. 7D, Condition 2). These results indicate that F6, but not OSCP, plays a primary role in making the top of F1 inaccessible to the alpha  subunit-deblocking enzyme. Results obtained with an antibody to subunit d not presented here, although less clear, mimicked most closely those obtained with F6, indicating that subunit d may also shield in part the top of F1.


View larger version (47K):
[in this window]
[in a new window]
 
Fig. 7.   A, N-terminal sequence of the F1 alpha  subunit obtained after prior treatment of F0F1 with the detergent CHAPS and then with the deblocking enzyme pyroglutamate amino peptidase. F0F1 (200 µg) was incubated for 12 h at 4 °C and then for 2 h at 25 °C in a 0.2-ml system containing 100 mM sodium Pi, pH 8.0, 10 mM EDTA, 5 mM DTT, 5% glycerol, and 0.6% CHAPS. Following SDS-PAGE, the alpha  subunit band was subjected to N-terminal sequence analysis exactly as described under "Methods." B, absence of N-terminal sequence data for the alpha  subunit upon treating F0F1 as in A but in the presence of urea. All conditions were exactly as in A with the exception that 1 M urea was present. In control studies, urea was shown to be without effect on the activity of the deblocking enzyme. C, Western blots obtained with an antibody to the F0 subunit "F6" following SDS-PAGE of detergent extracts of F0F1 treated as in A or as in B. F0F1 samples were treated exactly as in A with or without urea and then centrifuged at 14,000 rpm for 15 min in a microcentrifuge at 25 °C. The supernatant was removed and boiled for 20 min and then centrifuged at 14,000 rpm for 30 min at 25 °C. The final supernatant was then removed and subjected to SDS-PAGE/Western blot analysis exactly as described under "Methods" using a polyclonal antibody to F6. D, experiments were carried out exactly as described in C using a polyclonal antibody to OSCP rather than F6.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The novel set of studies reported here were undertaken to gain greater insight into the predicted motor-related features of ATP synthases from animal cells. The objectives were 3-fold and focused on (a) identifying exterior regions at the top and bottom of the F1 motor that are shielded by F0; (b) determining the importance of these regions for coupling an electrochemical proton gradient via the motor in F0 to the synthesis of ATP on F1; and (c) identifying one or more F0 subunits unique to animal ATP synthases involved in shielding F1. Each of these objectives was achieved either fully or in part.

Clearly, as revealed by N-terminal sequence analyses (Figs. 1 and 2), exterior regions at both the top and bottom of rat liver F1 within the complete ATP synthase are shielded from limited proteolysis arising from endogenous proteases during purification. Shielded regions include the N-terminal regions of all alpha  and beta  subunits, which are known from the atomic resolution structure of rat liver F1 to reside at its top (28), and the N-terminal region of the single delta  subunit, which is inferred from biochemical studies to reside at its bottom (25). Treatment of the complete ATP synthase (F0F1) with trypsin is also without effect on the N-terminal regions of these same subunits, providing additional support that they are shielded by F0. These finding, although identifying potential F0/F1 contact regions in the complete rat liver ATP synthase, also implicate F1 as being "capped" at its top by one or more subunits derived from F0 and shielded at its bottom.

Significantly, the exterior N-terminal regions of F1, which are shielded from limited proteolysis during isolation of F0F1, i.e. the QK dipeptide of the alpha  subunit (Fig. 2E), the AAQSSA hexapeptide of the beta  subunit (Fig. 2E), and the AQAA tetrapeptide of the delta  subunit (Fig. 3G), are not required for F1 to restore ATP synthesis to F1-depleted inner membrane vesicles (Fig. 6B). However, if the endogenously shaved F1 preparation is shaved further at both its top and bottom by exogenously added trypsin, the enzyme is unable to catalyze ATP synthesis when reconstituted with F1-depleted inner membrane vesicles (Fig. 6B). This loss of physiological function occurs despite the fact that the more closely shaved F1 fully retains both its catalytic ATPase activity (Fig. 6A) and its capacity to bind in a normal manner to F1-depleted inner membrane vesicles (Fig. 6B). Specifically, trypsin removes from the alpha  subunit's N-terminal region an additional 13 amino acids, TGTAEMSSILEER (Fig. 4C), and from its C-terminal region a 26-amino acid alpha -helix, SDGKISEQSDAKLKEIVTNFLAGFEP (Fig. 5B), while removing also the tripeptide APK from the N-terminal region of the beta  subunit (Fig. 4D). Taken together, these findings summarized in Fig. 8A indicate that one or more of these trypsin-cleaved exterior regions, which are also shielded by F0 when within the complete ATP synthase (Figs. 2, 3, and 5), are critical for the capacity of F1 to couple an electrochemical proton gradient to the synthesis of ATP.


View larger version (56K):
[in this window]
[in a new window]
 
Fig. 8.   A, summary of exterior regions of F1 subunits shielded by F0 that are nonessential for mitochondrial ATP synthesis, and those of which one or more is essential. Blue italicized letters designate those exterior amino acid residues that are not essential, while red letters inside dotted boxes designate those of which one or more is essential. B, model of rat liver mitochondrial ATP synthase incorporating conclusions derived from the novel findings reported here. Experimental data reported here are consistent with a model for animal ATP synthases in which (a) one or more F0 subunits completely shields the top of F1 forming a cap; (b) one or more F0 subunits also shields the bottom of the F1 headpiece, perhaps forming a collar; and (c) components of F1, most likely delta  and epsilon , shield the gamma  subunit within the region of the central stalk at the bottom of F1. The data reported are consistent also with a role for the unique F0 subunit F6 in helping shield F1, most likely at its top, although another location cannot be completely ruled out.

Additional results presented here provide new information about the relationship of F0 in the complete ATP synthase to the central stalk region of F1, i.e. the region that extends from the bottom of the F1 headpiece to the basepiece of F0, a distance of about 50 Å (30). From SDS-PAGE, N-terminal sequencing, and mass spectral studies following treatment with trypsin (Figs. 4 and 5), it is clear that gamma  subunit is already well protected in the central stalk region within F1. This shield is likely provided, at least in part, by the delta  subunit of F1, a view that is supported by previous work in this laboratory on rat liver F1 (25) and from the low resolution structure of yeast F1 in complex with a decamer of the subunit c of F0 (30). The epsilon  subunit of F1, which binds to the delta  subunit (50), may also comprise, in part, the shield that protects the gamma  subunit within F1. Because studies reported here implicate F0 as shielding the N-terminal region of the delta  subunit (Fig. 3, C and D), it would appear that in the intact ATP synthase complex, one or more components of F0 may reside sufficiently near the central stalk region to form contacts, but that these contacts may not be directly in contact with the gamma  subunit. In other words, the gamma  subunit in the central stalk region may be doubly shielded, with the first layer involving the delta  and epsilon  subunits of F1, and the second shield one or more subunits of F0.

Finally, studies reported here show that those conditions that make the N-terminally blocked residue (Q*) of the alpha  subunit at the top of F1 accessible in F0F1 to a deblocking enzyme also result in the release of the F0 subunit called F6 (Fig. 7). Moreover, conditions that prevent the N-terminally blocked residue from becoming accessible to the deblocking enzyme also prevent the release of F6 (Fig. 7). These findings are consistent with a location, or partial location, of F6 at the top of F1 in the complete ATP synthase complex of rat liver, although they do not exclude its interaction or partial interaction at other locations. Significantly, F6, a small 8.93-kDa protein, required for ATP synthesis in inner mitochondrial membrane vesicles (52), is not found among the F0 subunits in the simpler ATP synthase preparations derived from E. coli and chloroplasts (1-3). Therefore, the novel finding reported here about F6 is of special interest, and in future studies may help reveal why the F0 unit of animal ATP synthases are much more complex than the F0 units of the E. coli and chloroplast enzymes.

When conclusions from all the studies described here are considered, we envision an overall structural model for the rat liver ATP synthase in which one or more components of F0 extend from its basepiece to the top of the headpiece of F1 (Fig. 8B). At the bottom of F1, components of F0 are considered to associate closely or "hug" the central stalk region forming a "collar" that shields the C-terminal regions of the three alpha  subunits. At the top of F1, the extension of this "second stalk" is considered to cover completely the N-terminal regions of all alpha  and beta  subunits, thus providing a "cap." In addition, the cap may be composed, at least in part, by the F0 subunit F6, unique to animal ATP synthases. This model, derived from using a variety of approaches and methodologies, is consistent with current views about ATP synthase structure, which envision the presence of a stator connecting two motors, one within the F1 headpiece and another within the F0 basepiece (31-33, 35). In addition, this model and the experimental work on which it is based provide biochemical support for the recent electron microscopic study of bovine heart ATP synthase, showing a collar around the central stalk and a mass at the top of the F1 (11), and support for a similar study conducted on the E. coli ATP synthase in which a mass was also observed on the top of F1 (12). Taken together, these studies suggest that earlier models (53-55) depicting the stator or second stalk as interacting with only one alpha beta pair and failing to extend from the basepiece of F0 to the top of F1 may require revision.

Significantly, the extension of the stator to the top of F1 may have important functional consequences, because not one but all three alpha beta pairs containing the catalytic sites must be stabilized during ATP synthesis. Moreover, that part of the stator that resides at the top may be important also in facilitating formation of those critical contacts recently suggested to be important in the assembly of the beta -barrel domains (56).

    ACKNOWLEDGEMENTS

We are grateful to Jodie Franklin for help in obtaining N-terminal sequence and mass spectral data on F1, and to Drs. Youssef Hatefi and Akemi Matsuno-Yagi for supplying antibodies to F0 subunits.

    FOOTNOTES

* This work was supported by National Institutes of Health Grant CA 10951 (to P. L. P.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The amino acid sequence of this protein can be accessed through NCBI Protein Database under NCBI accession numbers: P15999 (alpha ), P10719 (beta ), P35435 (gamma ), P35434 (delta ), and P29418 (epsilon ).

Dagger To whom correspondence should be addressed: Dept. of Biological Chemistry, Johns Hopkins University, School of Medicine, 725 North Wolfe St., Baltimore, MD 21205-2185. Tel.: 410-955-3827; Fax: 410-614-1944; E-mail: ppederse@welchlink.welch.jhu.edu.

Published, JBC Papers in Press, July 7, 2000, DOI 10.1074/jbc.M004453200

    ABBREVIATIONS

The abbreviations used are: DTT, dithiothreitol; DCCD, N, N'-dicyclohexylcarbodiimide; CHAPS, [3-cholamidopropyl]dimethylammonio-1-propanesulfonate; CAPS, 3-(cyclohexylamino)propanesulfonic acid; TRICINE, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl] glycine; PAGE, polyacrylamide gel electrophoresis; PVDF, polyvinylidene difluoride; MALDI-TOF MS, matrix-assisted laser desorption time of flight mass spectrometry; AEBSF, 4-(2-aminoethyl)benzenesulfonylfluoride hydrochloride; IMV, inner membrane vesicle(s); OSCP, oligomycin sensitivity conferring protein.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Weber, J., and Senior, A. E. (1997) Biochim. Biophys. Acta 1319, 19-58
2. Boyer, P. D. (1997) Annu. Rev. Biochem. 66, 714-749
3. Altendorf, K., Stalz, W.-D., Greie, J.-C., and Deckers-Hebestreit, G. (2000) J. Exp. Biol. 203, 19-28
4. Kagawa, Y. (1972) Biochim. Biophys. Acta 265, 297-338
5. Soper, J. W., Decker, G. L., and Pedersen, P. L. (1979) J. Biol. Chem. 254, 11170-11176
6. McEnery, M. W., Buhle, E. L., Jr., Aebi, U., and Pedersen, P. L. (1984) J. Biol. Chem. 259, 4642-4651
7. Gogel, E. P., Lucken, U., and Capaldi, R. A. (1987) FEBS Lett. 219, 274-278
8. Wilkens, S., Dunn, S. D., and Capaldi, R. A. (1994) FEBS Lett. 354, 37-40
9. Birkenhagen, R., Hoppert, M., Deckers-Hebestreit, G., Mayer, F.,